- Home
- APWC vs MREO Comparison
APWC vs MREO Comparison
Compare APWC & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APWC | MREO |
|---|---|---|
| Founded | 1996 | 2015 |
| Country | Taiwan | United Kingdom |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.4M | 50.3M |
| IPO Year | 1997 | 2017 |
Fundamental Metrics
Financial Performance| Metric | APWC | MREO |
|---|---|---|
| Price | $1.40 | $0.25 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 8.4K | ★ 5.2M |
| Earning Date | 04-29-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.67 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $500,000.00 |
| Revenue This Year | N/A | $5,184.20 |
| Revenue Next Year | N/A | $55.51 |
| P/E Ratio | $12.60 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.27 | $0.20 |
| 52 Week High | $2.34 | $2.37 |
Technical Indicators
Market Signals| Indicator | APWC | MREO |
|---|---|---|
| Relative Strength Index (RSI) | 42.25 | 36.56 |
| Support Level | $1.30 | $0.22 |
| Resistance Level | $1.48 | $0.35 |
| Average True Range (ATR) | 0.05 | 0.02 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 31.79 | 12.61 |
Price Performance
Historical ComparisonAbout APWC Asia Pacific Wire & Cable Corporation Ltd. (Bermuda)
Asia Pacific Wire & Cable Corp Ltd is a holding company. It is principally engaged in the manufacture and distribution of enameled wire, power cable, and telecommunications products in Thailand, Singapore, Australia, the PRC, Hong Kong, and certain other markets in the Asia Pacific region. It also provides project engineering services in the supply, delivery, and installation of power cables (SDI). Some of the company's products are Bare wires, Power cables, Communication cables, Electronic wires & cables, and Enamelled wires. The company's geographical segments are North Asia, Thailand, and the rest of the World.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).